Product Use Citations
-
Elkabets M, et al. AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas.
Cancer Cell. 2015, 27(4):533-46.
Crizotinib (PF-02341066) , Erlotinib HCl (OSI-744) and AZD8055 purchased from Selleck.
-
Nold-Petry CA, et al. IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction.
Nat Immunol. 2015, 16(4):354-365.
UNC2250 purchased from Selleck.
-
Gallant JN, et al. EGFR kinase domain duplication (EGFR-KDD) is a novel oncogenic driver in lung cancer that is clinically responsive to afatinib
Cancer Discov. 2015, 5(11):1155-63.
Osimertinib (AZD9291) purchased from Selleck.
-
Jin K, et al. HOXB7 is an ERα cofactor in the activation of HER2 and multiple ER target genes leadingto endocrine resistance
Cancer Discov. 2015, 5(9):944-59.
10058-F4 purchased from Selleck.
-
Jonas O, et al. An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors.
Sci Transl Med. 2015, 7(284):284ra57.
Dasatinib , Lapatinib and Sunitinib Malate purchased from Selleck.
-
Chen G, et al. Intrathecal bone marrow stromal cells inhibit neuropathic pain via TGF-β secretion
J Clin Invest. 2015, 10.1172/JCI80883.
SB431542 , Plerixafor (AMD3100) and Plerixafor 8HCl (AMD3100 8HCl) purchased from Selleck.
-
Kim KH, et al. CCN1 induces hepatic ductular reaction through integrin αvβ5-mediated activation of NF-κB.
J Clin Invest. 2015, 10.1172/JCI79327.
Cilengitide trifluoroacetate purchased from Selleck.
-
Rees MG, et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action
Nat Chem Biol. 2015, 10.1038/nchembio.1986.
Obatoclax Mesylate (GX15-070) , RITA (NSC 652287) purchased from Selleck.
-
Jia XE, et al. Mutation of kri1l causes definitive hematopoiesis failure via PERK-dependent excessive autophagy induction
Cell Res. 2015, 25(8):946-62.
GSK2656157 purchased from Selleck.
-
Hamasy A, et al. Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant
Leukemia. 2016, 10.1038/leu.2016.153.
Ibrutinib (PCI-32765) purchased from Selleck.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
AllPage:
Page:
